AFP and hepatocellular carcinoma: ,21 Identifying promising blood-based DNA methylation markers that could be combined with current clinical markers of HCC (eg, alpha-feto protein [AFP], lectin-reactive AFP [AFP-L3], and des-γ-carboxy prothrombin [DCP]) could enhance clinical surveillance through noninvasive screening for metabolic HCC.